-
1دورية أكاديمية
المؤلفون: Aroda, Vanita R., Erhan, Umut, Jelnes, Peter, Meier, Juris J., Abildlund, Morten Tind, Pratley, Richard, Vilsbøll, Tina, Husain, Mansoor
المصدر: Aroda , V R , Erhan , U , Jelnes , P , Meier , J J , Abildlund , M T , Pratley , R , Vilsbøll , T & Husain , M 2023 , ' Safety and tolerability of semaglutide across the SUSTAIN and PIONEER phase IIIa clinical trial programmes ' , Diabetes, Obesity and Metabolism , vol. 25 , no. 5 , pp. 1385-1397 . https://doi.org/10.1111/dom.14990Test
مصطلحات موضوعية: antidiabetic drug, GLP-1, phase III study, randomized trial, type 2 diabetes
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1111/dom.14990Test
https://curis.ku.dk/portal/da/publications/safety-and-tolerability-of-semaglutide-across-the-sustain-and-pioneer-phase-iiia-clinical-trial-programmesTest(6dfb69dc-bb75-47b4-9dee-55ea56059d8f).html
https://curis.ku.dk/ws/files/365703618/Diabetes_Obesity_Metabolism_2023_Aroda.pdfTest -
2دورية أكاديمية
المصدر: Del Prato , S , Gallwitz , B , Holst , J J & Meier , J J 2022 , ' The incretin/glucagon system as a target for pharmacotherapy of obesity ' , Obesity Reviews , vol. 23 , no. 2 , e13372 . https://doi.org/10.1111/obr.13372Test
مصطلحات موضوعية: dual agonist, GLP-1, glucagon, overweight
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1111/obr.13372Test
https://curis.ku.dk/portal/da/publications/the-incretinglucagon-system-as-a-target-for-pharmacotherapy-of-obesityTest(17327ba7-946c-43bd-a114-170647c8aba0).html
https://curis.ku.dk/ws/files/289460630/Obesity_Reviews_2021_Del_Prato_The_incretin_glucagon_system_as_a_target_for_pharmacotherapy_of_obesity.pdfTest -
3دورية أكاديمية
المصدر: Diabetes, Obesity & Metabolism; Nov2023, Vol. 25 Issue 11, p3079-3092, 14p
مصطلحات موضوعية: GLUCAGON-like peptide 1, REGULATION of body weight, GLYCEMIC control, HORMONE receptors, TYPE 2 diabetes, PEPTIDE receptors, CLINICAL trials
-
4دورية أكاديمية
المؤلفون: Rosenstock, Julio, Handelsman, Yehuda, Vidal, Josep, Ampudia Blasco, F. Javier, Giorgino, Francesco, Liu, Minzhi, Perfetti, Riccardo, Meier, Juris J.
المساهمون: Rosenstock, Julio, Handelsman, Yehuda, Vidal, Josep, Ampudia Blasco, F. Javier, Giorgino, Francesco, Liu, Minzhi, Perfetti, Riccardo, Meier, Juris J.
مصطلحات موضوعية: GLP-1, glycaemic control, insulin therapy, type 2 diabete, Internal Medicine, Endocrinology, Diabetes and Metabolism
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29974618; info:eu-repo/semantics/altIdentifier/wos/WOS:000449659500012; volume:20; issue:12; firstpage:2821; lastpage:2829; numberofpages:9; journal:DIABETES, OBESITY AND METABOLISM; http://hdl.handle.net/11586/222531Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85052652789; http://onlinelibrary.wiley.com/journal/10.1111Test/(ISSN)1463-1326
-
5دورية أكاديمية
المؤلفون: Müller, Timo D., Finan, Brian, Bloom, S.R., D'Alessio, David, Drucker, Daniel J., Flatt, P.R., Gribble, Fiona, Grill, Harvey J., Habener, Joel F., Holst, Jens J., Langhans, Wolfgang, Meier, Juris J., Nauck, Michael A., Perez-Tilve, Diego, Pocai, A., Reimann, Frank, Sandoval, Darleen A., Schwartz, Thue W., Seeley, Randy J., Stemmer, Kerstin, Tang-Christensen, Mads, Woods, Stephen C., DiMarchi, Richard D., Tschöp, Matthias H.
المصدر: Molecular Metabolism, 30
وصف الملف: application/application/pdf
العلاقة: info:eu-repo/semantics/altIdentifier/wos/000500474800006; http://hdl.handle.net/20.500.11850/371733Test
الإتاحة: https://doi.org/20.500.11850/371733Test
https://doi.org/10.3929/ethz-b-000371733Test
https://doi.org/10.1016Test/j.molmet.2019.09.010
https://hdl.handle.net/20.500.11850/371733Test -
6دورية أكاديمية
المؤلفون: Meier, Juris J.1,2 (AUTHOR) juris.meier@ruhr-uni-bochum.de, Quast, Daniel R.1 (AUTHOR), Nauck, Michael A.1 (AUTHOR), Schenker, Nina1 (AUTHOR), Deacon, Carolyn F.3 (AUTHOR), Holst, Jens J.3 (AUTHOR), Plum‐Mörschel, Leona4 (AUTHOR), Kapitza, Christoph5 (AUTHOR)
المصدر: Diabetes, Obesity & Metabolism. May2022, Vol. 24 Issue 5, p806-815. 10p.
مصطلحات موضوعية: *SODIUM-glucose cotransporters, *GASTRIC inhibitory polypeptide, *TYPE 2 diabetes, *LINAGLIPTIN, *PEOPLE with diabetes, *CD26 antigen
-
7دورية أكاديمية
المؤلفون: Meier, Juris J.1 juris.meier@rub.de, Schenker, Nina1, Kahle, Melanie1, Schliess, Freimut2, Kapitza, Christoph2, Menge, Björn A.1
المصدر: Diabetes, Obesity & Metabolism. Nov2017, Vol. 19 Issue 11, p1625-1629. 5p.
مصطلحات موضوعية: *TYPE 2 diabetes treatment, *INSULIN therapy, *GLUCAGON-like peptide-1 agonists, *PANCREATIC beta cells, *COMBINATION drug therapy, *PHYSIOLOGY, *THERAPEUTICS
-
8دورية أكاديمية
المؤلفون: Nauck, Michael A.1 michael.nauck@rub.de, Meier, Juris J.1, Cavender, Matthew A.2, El Aziz, Mirna Abd1, Drucker, Daniel J.3, Abd El Aziz, Mirna4 (AUTHOR)
المصدر: Circulation. 8/29/2017, Vol. 136 Issue 9, p849-870. 22p.
مصطلحات موضوعية: *MYOCARDIAL infarction, *CARDIOVASCULAR diseases, *CONGESTIVE heart failure, *GLUCAGON-like peptide-1 agonists, *INCRETINS, *STROKE, *CORONARY heart disease prevention, *THERAPEUTIC use of protease inhibitors, *HYPOGLYCEMIC agents, *HEART ventricle diseases, *META-analysis, *TYPE 2 diabetes, *GLUCAGON-like peptide 1, *SYSTEMATIC reviews
-
9دورية أكاديمية
المؤلفون: Kampmann, Kirsten, Ueberberg, Sandra, Menge, Bjoern A., Breuer, Thomas G.K., Uhl, Waldemar, Tannapfel, Andrea, Meier, Juris J.
المصدر: Metabolism: Clinical & Experimental; Mar2016, Vol. 65 Issue 3, p84-91, 8p
مصطلحات موضوعية: PEOPLE with diabetes, GASTROINTESTINAL hormones, MUCOUS membranes, ENTEROENDOCRINE cells, CHROMOGRANINS, INSULIN synthesis
-
10دورية أكاديمية
المؤلفون: Nauck, Michael A.1 M.Nauck@diabeteszentrum.de, Meier, Juris J.2
المصدر: Regulatory Peptides. Jun2005, Vol. 128 Issue 2, p135-148. 14p.
مصطلحات موضوعية: *GLUCAGON-like peptide 1, *NUTRITION & psychology, *PANCREATIC secretions, *CARBOHYDRATE intolerance